Effect of insulin sensitivity, insulin secretion, and beta cell function on the remission of type 2 diabetes: A post hoc analysis of the IDEATE trial
Wu X, Huang Q, Ding Y, et al.
Diabetes Obes Metab. Pub. online 13 Jan 2025.
Leggi
Breaking news
Cardiac metabolic index as a predictor of new-onset diabetes in non-alcoholic fatty liver disease patients: a longitudinal cohort analysis
Hou S, Wang Y, Wei Z, et al.
BMC Endocr Disord. 2025;25(1):13.
Leggi
Beyond glycated haemoglobin: modelling contemporary management of type 2 diabetes with the updated Cardiff model
McEwan P, Foos V, Roberts G, et al.
Diabetes Obes Metab. Pub. online 19 Jan 2025.
Leggi
Derivation and validation of D-RISK: an electronic health record-driven risk score to detect undiagnosed dysglycemia in clinical practice
Bowen ME, Lingvay I, Meneghini L, et al.
Diabetes Care. 2025:dc241624.
Leggi
Effect of pediatric obesity treatment on long-term health
Putri RR, Danielsson P, Ekström N, et al.
JAMA Pediatr. Pub. online 21 Jan 2025.
Leggi
Targeting ultra-processed foods for prevention of type 2 diabetes: state of the evidence and future directions
Mendoza K, Barquera S, Tobias DK
Diabetologia. Pub. online 18 Jan 2025.
Leggi
AIFA: Parere favorevole all’ammissione alla rimborsabilità del medicinale «Baqsimi» per il trattamento dell’ipoglicemia severa
17/12/2024
Leggi
Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial
Lingvay I, Benamar M, Chen L, et al.
Diabetologia. Pub. online 17 Jan 2025.
Leggi
Subgroup analysis by sex and baseline BMI in people with a BMI ≥27 kg/m2 in the phase 2 trial of survodutide, a glucagon/GLP-1 receptor dual agonist
le Roux CW, Steen O, Lucas KJ, et al.
Diabetes Obes Metab. Pub. online 16 Jan 2025.
Leggi
Three-year follow-up after antiviral treatment in new-onset type 1 diabetes: results from the diabetes virus detection and intervention trial
Mynarek IM, Krogvold L, Mørk FB, et al.
Diabetes Care. 2025:dc242121.
Leggi